Assessing the Clinical Relevance of Brca1-ring Domain Variants of Uncertain Significance

Loading...
Thumbnail Image

Authors

Martin, Matthew David

Date

2025-09-25

Type

thesis

Language

eng

Keyword

BRCA1 , Cancer , Breast , Ovarian , Tumor Supressor , VUS

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

BRCA1 serves multiple genome integrity functions critical for suppressing tumor development. Women who inherit BRCA1 Variants of Uncertain Significance (VUS) face uncertainty about whether their variant is benign, or pathogenic and substantially increases their risk of breast and ovarian cancer. Considering that the N-terminal BRCA1-RING domain harbors over 500 missense VUS and appears essential to the critical function of the full protein, a domain-specific machine learning algorithm combined with a BARD1 co-immunoprecipitation assay was used to predict the functional impacts of variants. The computational and in vitro evidence warrants reclassification of two VUS as likely-benign (N16S, E100D) and two as likely-pathogenic (C27R, H41P), and one as pathogenic (C24G) which will improve preventative care decisions for carriers. Five more received evidence that shifts them towards a likely-pathogenic (L86R, I68T) and likely-benign (Q54P, C91R, K20Q) classification.

Description

Citation

Publisher

License

Queen's University's Thesis/Dissertation Non-Exclusive License for Deposit to QSpace and Library and Archives Canada
Intellectual Property Guidelines at Queen's University
Copying and Preserving Your Thesis
This publication is made available by the authority of the copyright owner solely for the purpose of private study and research and may not be copied or reproduced except as permitted by the copyright laws without written authority from the copyright owner.
Attribution-NonCommercial 4.0 International

Journal

Volume

Issue

PubMed ID

External DOI

ISSN

EISSN